TMDI - Earnings announcements

TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (NASDAQ:TMDI, TSX:TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three and nine months ended September 30, 2022. Additionally, the company announced that a special meeting of shareholders will be held virtually on January 12, 2023 to seek shareholder approval for a consolidation of its common shares, including for the purposes of demonstrating compliance with Nasdaq Rule 5550(a)(2). As previously shared, Nasdaq granted the company with an extension to regain compliance

TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (NASDAQ:TMDI, TSX:TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three and six months ended June 30, 2022. "I am thrilled to lead Titan Medical as President and CEO and have been committed to the company's mission to improve surgical outcomes as a director of the company since September 2020. We continue to make progress on impacting the future of minimally invasive robotic surgery and the operating room ecosystem. Our technical partnerships, our relationships with surg

Manufacturing Team and Capabilities Continue to Expand Titan Medical Inc. (NASDAQ:TMDI, TSX:TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three months ended March 31, 2022. "The entire team is focused on driving performance and progress supporting our IDE application submission milestone. We are also starting to prepare for the forthcoming commercialization of the Enos single-access RAS platform for gynecological surgery, our initial target indication for use," stated Paul Cataford, Interim President, CEO and Board Chair. "We are

Titan Medical Inc. (NASDAQ:TMDI, TSX:TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery today announced that the company plans to issue its third quarter 2021 financial results prior to market opening on Thursday, November 11, 2021. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business highlights. Speakers will include David McNally, President and Chief Executive Officer, and Stephen Lemieux, Chief Financial Officer. A link to the live audio webcast will be made available on the "Investor Relations" section of the Company's w

Titan Medical Inc. (NASDAQ:TMDI, TSX:TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that the company plans to issue its second quarter 2021 financial results prior to market opening on Wednesday, August 11, 2021. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business highlights. Speakers will include David McNally, President and Chief Executive Officer, and Stephen Lemieux, Chief Financial Officer. A link to the live audio webcast will be made available on the "Investor Relations" section of the Company's website, www.titanmedicali

Paul Cataford Appointed Chairman of the Board Heather Knight Appointed as Independent Director Cathy Steiner Nominated for Election as Independent Director Titan Medical Inc. (NASDAQ:TMDI, TSX:TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces financial results for the three months ended March 31, 2021. During the first quarter of 2021 the company raised proceeds of $34.5 million from two equity financings and $10 million from the exercise of warrants issued to investors in previous offerings. Titan also announces changes to its board of directors appointing Paul Cataford as Chairman of the Board and He